UBS Group »

Ovid Therapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Ovid Therapeutics (OVID) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Ovid Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ovid Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ovid Therapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $232k 72k 3.22
2023-09-30 $185k 48k 3.84
2023-06-30 $163k 50k 3.28
2023-03-31 $47k 18k 2.59
2022-12-31 $31k 17k 1.86
2022-09-30 $37k 19k 1.92
2022-06-30 $34k 16k 2.12
2022-03-31 $47k 15k 3.13
2021-12-31 $62k 19k 3.20
2021-09-30 $50k 15k 3.33
2021-06-30 $59k 15k 3.93
2021-03-31 $81k 20k 4.05
2020-12-31 $2.4M 1.0M 2.31
2020-09-30 $2.6M 450k 5.74
2020-06-30 $1.1M 133k 8.29
2020-03-31 $620k 208k 2.98
2019-12-31 $17k 4.0k 4.27
2019-06-30 $13k 6.9k 1.90
2018-12-31 $24k 10k 2.38
2018-09-30 $19k 3.3k 5.76
2018-06-30 $23k 3.0k 7.73
2017-12-31 $2.0k 227 8.81
2017-09-30 $15k 1.8k 8.47